Arecor Therapeutics (AREC) Stock Chart & Stock Price History GBX 49.30 +0.30 (+0.61%) As of 07/18/2025 08:42 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Arecor Therapeutics Stock Price Performance The Arecor Therapeutics (AREC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 46.30%, with a year-to-date return of -33.15%. In the past month, the stock has increased 16.55%, reflecting recent market activity. As of the latest close, Arecor Therapeutics traded at GBX 49.30 with a market cap of £18.61 million and volume of 18,949 shares. Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.14%1 Month Performance+16.55%3 Month Performance+25.13%Year-To-Date Performance-33.15%1 Year Performance-46.30% AREC Stock Chart for Sunday, July, 20, 2025 AREC Chart by TradingView Arecor Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025GBX 49GBX 49.30+0.61%GBX 49.30GBX 4818,949 shs£18.61 million07/17/2025GBX 48.12GBX 49+1.83%GBX 50GBX 4857,929 shs£18.50 million07/16/2025GBX 49.37GBX 48.12-2.53%GBX 50GBX 48.1234,202 shs£18.17 million07/15/2025GBX 49.38GBX 49.37-0.02%GBX 49.37GBX 471,412 shs£18.64 million07/14/2025GBX 48.64GBX 49.38+1.52%GBX 49.44GBX 48.0512,358 shs£18.64 million07/11/2025GBX 48.40GBX 48.64+0.50%GBX 48.64GBX 4828,474 shs£18.37 million07/10/2025GBX 48.40GBX 48.40GBX 48.40GBX 47.503,088 shs£18.27 million07/09/2025GBX 47.67GBX 48.40+1.53%GBX 48.40GBX 47.501,446 shs£18.27 million07/08/2025GBX 44GBX 47.67+8.34%GBX 47.70GBX 45553,861 shs£18.00 million07/07/2025GBX 44.50GBX 44-1.12%GBX 46.87GBX 44356,977 shs£16.61 million Get the Latest News and Ratings for AREC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025GBX 43.17GBX 43.17GBX 43.50GBX 43.1775,000 shs£16.30 million07/03/2025GBX 43.18GBX 43.17-0.02%GBX 43.50GBX 43.1775,000 shs£16.30 million07/02/2025GBX 43.18GBX 43.18GBX 43.18GBX 42.023,490 shs£16.30 million07/01/2025GBX 42.30GBX 43.18+2.08%GBX 45GBX 422,646 shs£16.30 million06/30/2025GBX 42.30GBX 42.30GBX 43.50GBX 42.302,352 shs£15.97 million06/27/2025GBX 42GBX 42.30+0.71%GBX 45GBX 42.3051 shs£15.97 million06/26/2025GBX 42.30GBX 42-0.71%GBX 42.30GBX 422,173 shs£15.86 million06/25/2025GBX 42.30GBX 42.30GBX 43.50GBX 42.301,000 shs£15.97 million06/24/2025GBX 42GBX 42.30+0.71%GBX 43.50GBX 42.301,000 shs£15.97 million06/23/2025GBX 42.30GBX 42-0.71%GBX 43.70GBX 4210,896 shs£15.86 million06/20/2025GBX 42.40GBX 42.30-0.24%GBX 43.50GBX 42.30549 shs£15.97 million06/19/2025GBX 42.50GBX 42.40-0.24%GBX 42.40GBX 414,377 shs£16.01 million Related Companies hVIVO Stock Price Chart SkinBioTherapeutics Stock Price Chart Futura Medical Stock Price Chart Tissue Regenix Group Stock Price Chart Sareum Stock Price Chart Poolbeg Pharma Stock Price Chart OptiBiotix Health Stock Price Chart IXICO Stock Price Chart Synairgen Stock Price Chart ImmuPharma Stock Price Chart Receive AREC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AREC) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
